The effect of community-based support services on clinical efficacy and health-related quality of life in HIV/AIDS patients in resource-limited settings in Sub-Saharan Africa

AIDS Patient Care and STDs

Volumn 24, Issue 9, 2010, Pages 581-594

  Kabore, Inoussa ^a   Bloem, Jeanette ^a   Etheredge, Gina ^a   Obiero, Walter ^a   Wanless, Sebastian ^b   Doykos, Patricia ^c   Ntsekhe, Pearl ^d   Mtshali, Nomantshali ^e   Afrikaner, Eric ^f   Sayed, Rauf ^g   Bostwelelo, John ^f   Hani, Andiswa ^f   Moshabesha, Tiisetso ^f   Kalaka, Agnes ^f   Mameja, Jerry ^f   Zwane, Nompumelelo ^f   Shongwe, Nomvuyo ^f   Mtshali, Phangisile ^h   Mohr, Beryl ^h   Smuts, Archie ^h   Tiam, Appolinaire ^d   more..

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c BMSF   (United States)

^d Senkatana Centre   (Lesotho)

^e Mpilohnle Project   (South Africa)

^f School of Public Health and Family Medicine ^*

^g School of Public Health and Family Medicine   (South Africa)

^h BMSF   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AIDS PATIENT; ARTICLE; CD4+ T LYMPHOCYTE; COMMUNITY CARE; FEMALE; HEALTH CARE DELIVERY; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOME CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; QUALITY OF LIFE;

EID: 77956315271     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2009.0307     Document Type: Article

References (40)

1. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006;368:505-510.
2. The Sydney Declaration. Good research drives good policy and programming-a call to scale up research. Presented at: 4th International AIDS Society (IAS) Conference on Pathogenesis, Treatment and Prevention. Sydney, Australia: July 22-25, 2007.
3. Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004;20:1053-1056.
4. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Dam J. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian J Med Res 2008;127:28-36.
5. Burgoyne RW, Tan DH. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act. J Antimicrob Chemother. 2008;61:469-473.
6. Zachariaha R, Teck R, Buhendwa L, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg 2007;101:7984.
7. Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006;20:85-92.
8. Watt MH, Maman S, Earp JA, et al. "It s all the time in my mind": Facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med 2009;68:1793-800.
9. Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: Programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J 2006;96:315-320.
10. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to anti-retroviral therapy: The experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004;18(Suppl 3):S27-S31.
11. Djomand G, Roels T, Ellerbrock T, et al. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d Ivoire. AIDS 2003;17(Suppl 3):S5-S15.
12. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet 2006;367:1335-1342.
13. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature. Clin Infect Dis 2005;41: 217-224.
14. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of anti-retroviral therapy at primary care sites in Zambia: Feasibility and early outcomes. JAMA 2006;296:782-793.
15. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: Patients response, survival, and drug resistance. Lancet 2002;360:34-40.
16. Koenig SP, Leandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: The rural Haiti experience. AIDS 2004;18(Suppl 3):S21-S25.
17. Nachega JB, Knowlton AR, Deluca A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S127-S133.
18. Bristol-Myers Squibb. Secure the Future Manual: Seven Steps to Involve the Community in HIV/AIDS Treatment Support Programmes. New York, NY: Bristol-Myers Squibb, 2007.
19. World Health Organization. WHOQoL Study Protocol (MNH7PSF/93.9). Geneva, Switzerland: World Health Organization, 1993.
20. World Health Organization. WHOQOL-HIV Instrument: Users Manual. Scoring and Coding for the WHOQOL-HIV Instruments. Geneva, Switzerland: Department of Mental Health and Substance Dependence, World Health Organization, 2002.
21. Murphy B, Herrman H, Hawthorne G, Pinzone T, Evert H. Australian WHOQoL instruments: User s manual and interpretation guide. Melbourne, Australia: Australian WHOQoL Field Study Centre, 2000.
22. Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS 2001;15: 1369-1377.
23. Bartlett JA, Fath M, DeMasi R, Quinn J, Hermes A, Rousseau F. An updated meta-analysis of triple combination therapy in antiretroviral-naive HIV-infected adults [CROI abstract 586]. Presented at: 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA: February 22-25, 2005.
24. Kuritzkes DR. Extending antiretroviral therapy to resource-poor settings: Implications for drug resistance. AIDS 2004; 18(Suppl 3):S45-S48.
25. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis 3 2005;191:339-347.
26. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
27. Lucas GM, Chaisson RE, Moore RD. Survival in an urban 3 HIV-1 clinic in the era of highly active antiretroviral therapy: A 5-year cohort study. J Acquir Immune Defic Syndr 2003; 33:321-328. 3
28. Krain A, Fitzgerald DW. HIV antiretroviral therapy in resource-limited settings: Experiences from Haiti. Curr HIV/ AIDS Rep 2005;2:98-104.
29. Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG, Bentley 3 ME. Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr 2005; 135:1093-1101. 3
30. Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003;17:1369-1375.
31. Weidle PJ, Wamai N, Solberg P, et al. Adherence to anti-4 retroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 2006;368:1587-1594.
32. Posse M, Baltussen R. Barriers to access to antiretroviral treatment in mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care STDs 2009;23:867-875.
33. Mshana GH, Wamoyi J, Busza J, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: A qualitative study of early rural referrals to the national program. AIDS Patient Care STDs 2006;20:649-657.
34. Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa, AIDS Care 2007;19:658-665.
35. Ramadhani HO, Thielman NM, Landman KZ, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis 2007;45: 1492-1498.
36. Dlamini PS, Wantland D, Makoae LN, et al. HIV stigma and missed medications in HIV-positive people in five African countries. AIDS Patient Care STDs 2009;23:377-387.
37. Ncama BP, McInerney PA, Bhengu BR, et al. Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa. Int J Nurs Stud 2008;45: 1757-1763.
38. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients adherence to antiretroviral treatment in Zambia: A qualitative study. SAHARA J 2008;5:136-143.
39. Ndekha MJ, Manary MJ, Ashorn P, Briend A. Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children. Acta Pædiatr 2005;94:222-225.
40. Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings: Decreasing barriers to access and promoting adherence. J Acquir Immune Defic Syndr 2006;43:S123-S126.